BioNTech SE ADR (NASDAQ: BNTX) is -8.14% lower on its value in year-to-date trading and has touched a low of $76.53 and a high of $131.49 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNTX stock was last observed hovering at around $101.81 in the last trading session, with the day’s gains setting it 2.87%.
Currently trading at $104.68, the stock is 10.18% and 1.12% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.19 million and changing 2.82% at the moment leaves the stock -0.74% off its SMA200. BNTX registered 21.48% gain for a year compared to 6-month loss of -8.55%. The firm has a 50-day simple moving average (SMA 50) of $103.5239 and a 200-day simple moving average (SMA200) of $105.46483.
The stock witnessed a 9.75% gain in the last 1 month and extending the period to 3 months gives it a -10.72%, and is 2.29% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.99% over the week and 5.57% over the month.
BioNTech SE ADR (BNTX) has around 6772 employees, a market worth around $25.12B and $2.98B in sales. Profit margin for the company is -24.07%. Distance from 52-week low is 36.78% and -20.39% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.53%).
with sales reaching $161.67M over the same period.The EPS is expected to shrink by -91.92% this year, but quarterly earnings will post -23.14% year-over-year. Quarterly sales are estimated to shrink -13.82% in year-over-year returns.
BioNTech SE ADR (BNTX) Top Institutional Holders
493.0 institutions hold shares in BioNTech SE ADR (BNTX), with institutional investors hold 59.52% of the company’s shares. The shares outstanding are 239.97M, and float is at 236.22M with Short Float at 1.54%. Institutions hold 21.89% of the Float.
The top institutional shareholder in the company is BAILLIE GIFFORD & CO with over 8.28 million shares valued at $665.08 million. The investor’s holdings represent 3.4425% of the BNTX Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 4.79 million shares valued at $384.89 million to account for 1.9922 of the shares outstanding. The other top investors are FLOSSBACH VON STORCH AG which holds 4.38 million shares representing 1.8216% and valued at over $351.94 million, while HARDING LOEVNER LP holds 1.2174 of the shares totaling 2.93 million with a market value of $235.22 million.
BioNTech SE ADR (BNTX) Insider Activity
#####
Still, SEC filings show that on Feb 20 ’25, Poetting Sierk (Officer) Proposed Sale 120,000 shares at an average price of $119.58 for $14.35 million. The insider now directly holds shares of BioNTech SE ADR (BNTX).
